ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Tumor Compactness based on CT to predict prognosis after multimodal treatment for esophageal squamous cell carcinoma

Wang, Qifeng; Cao, Bangrong; Chen, Junqiang; Li, Chen; Tan, Lijun; Zhang, Wencheng; Lv, Jiahua; Li, Xiqing; Xiao, Miyong; Lin, Yu; Lang, Jinyi; Li, Tao*; Xiao, Zefen*电子科技大学; 福建医科大学; 四川省肿瘤研究所; 中国医学科学院; 福建省肿瘤医院; 中国医学科学院北京协和医院
SCIENTIFIC REPORTS2019-7-19DOI: 10.1038/s41598-019-46899-x
5阅读
引用收藏
分享

摘要

We aimed to establish a risk model using computed tomography-based compactness to predict overall survival (OS) and progression-free survival (PFS) after multimodal treatment for esophageal squamous cell carcinoma (ES CC). We extracted pre-treatment computed tomography-based tumor data (volume, surface area, and compactness) for 512 cases of ESCC that were treated at 3 centers. A risk model based on compactness was trained using Cox regression analyses of data from 83 cases, and then the model was validated using two independent cohorts (98 patients and 283 patients). The largest cohort (283 patients) was then evaluated using the risk model to predict response to radiotherapy with or without chemotherapy. In the three datasets, the pre-treatment compactness risk model provided good accuracy for predicting OS (P = 0.012, P = 0.022, and P = 0.003) and PFS (P < 0.001, P = 0.003, and P= 0.005). Patients in the low-risk group did not experience a significant OS benefit from concurrent chemoradiotherapy (P= 0.099). Furthermore, after preoperative concurrent chemoradiotherapy, the OS outcomes were similar among patients in the low-risk group who did and did not achieve a pathological complete response (P= 0.127). Tumor compactness was correlated with clinical T stage but was more accurate for predicting prognosis after treatment for ESCC, based on higher C-index values in all three datasets. The compactness-based risk model was effective for predicting OS and PFS after multimodal treatment for ESCC. Therefore, it may be useful for guiding personalized treatment.

学科与关键词

关键词
POSITRON-EMISSION-TOMOGRAPHYNEOADJUVANT THERAPYCANCER STATISTICSCHEMORADIOTHERAPYRADIOTHERAPYCHINA
相关
加载中…
  • Decoding tumor stage by peritumoral and intratumoral radiomics in resectable esophageal squamous cell carcinoma
    Tan, Xian-Zheng*; Ma, Rong; Liu, Peng; Xiao, Chang-Hui; Zhang, Hui-Hui; Yang, Fan; Liang, Chang-Hong*; Liu, Zai-Yi*Abdominal Radiology, 2024, 49(1): 301-311.
  • Multiple Level CT Radiomics Features Preoperatively Predict Lymph Node Metastasis in Esophageal Cancer: A Multicentre Retrospective Study
    Wu, Lei; Yang, Xiaojun; Cao, Wuteng; Zhao, Ke; Li, Wenli; Ye, Weitao; Chen, Xin; Zhou, Zhiyang*; Liu, Zaiyi*; Liang, Changhong*Frontiers in Oncology, 2020, 9: 1548.被引 35
  • Prognostic significance of tumor regression grade in esophageal squamous cell carcinoma after neoadjuvant chemoradiation
    Zhang, Chi; Xu, Fei; Qiang, Yong; Cong, Zhuang-Zhuang; Wang, Qin; Zhang, Zheng; Luo, Chao; Qiu, Bing-Mei*; Hu, Li-Wen*; Shen, Yi*Frontiers in Surgery, 2023, 9: 1029575.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
SCIENTIFIC REPORTS
发表日期
2019-07-19
卷期
第 9 卷
页码
10497
DOI
10.1038/s41598-019-46899-x
成果收录
SCIE
资助标注
National Key Projects of Research and Development of China [2016YFC0904600]; Sichuan science and technology department key research and development project fund [JH2019006]; selected excellent projects for foundation from the science and technology projects of Sichuan Province (2016); Wu Jieping Medical Foundation [320.6750.17237]; Cancer Research Foundation of China Anti-cancer Association for Young Scientists [CAYC18A33]

作者

  • W

    Wang, Qifeng (第一作者)

    sichuan canc hosp & inst

  • C

    Cao, Bangrong

    sichuan canc hosp & inst

查看全部 13 位作者收起作者
  • C

    Chen, Junqiang

    fujian canc hosp · fujian med univ

  • L

    Li, Chen

    chinese acad med sci · peking union med coll

  • T

    Tan, Lijun

    chinese acad med sci · peking union med coll

  • Z

    Zhang, Wencheng

    peking union med coll

  • L

    Lv, Jiahua

    chinese acad med sci · sichuan canc hosp & inst

  • L

    Li, Xiqing

    fujian canc hosp · fujian med univ

  • X

    Xiao, Miyong

    sichuan canc hosp & inst

  • L

    Lin, Yu

    fujian canc hosp · fujian med univ

  • L

    Lang, Jinyi

    sichuan canc hosp & inst

  • L

    Li, Tao (通讯)

    sichuan canc hosp & inst

  • X

    Xiao, Zefen (通讯)

    chinese acad med sci · peking union med coll

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417